Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

(4-ethoxy-6-imino-5-((4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)hydrazono)-5,6-dihydro-1H-pyrimidin-2-ylidene)-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenylazo)acetonitrile MeSH Supplementary Concept Data 2025


MeSH Supplementary
(4-ethoxy-6-imino-5-((4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)hydrazono)-5,6-dihydro-1H-pyrimidin-2-ylidene)-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenylazo)acetonitrile
Unique ID
C476889
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C476889
Entry Term(s)
OR 1746
OR-1746
OR1746
Registry Numbers
0
Heading Mapped to
*Hydrazones
*Pyridazines
Frequency
1
Note
a cyclocondensation product derived from levosimendan; structure in first source
Source
J Pharm Biomed Anal 2003 Feb 5;31(1):125-31
Date of Entry
2003/09/03
Revision Date
2003/09/03
(4-ethoxy-6-imino-5-((4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)hydrazono)-5,6-dihydro-1H-pyrimidin-2-ylidene)-(4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenylazo)acetonitrile Preferred
OR 1746 Narrower
page delivered in 0.006s